A mobile app for rheumatology and treatment for reperfusion injury reduction are foci of the grants Boston, MA, August 26, 2024 --Two...

Everything You Wanted to Know About The FDA Regulatory Process For Therapeutics (But Were Afraid to Ask) Brigham and Women’s Hospital...

Brigham Ignite and iHub’s Navigating the World of Digital Health Collaboration with Industry, an in-person event, held on Thursday,...

Walid Ibn Essayed, MD, for long has had an undying passion for his specialty of neurosurgery. Years ago, his grandmother had died of a...

The Data-Centric Approach Yields Impactful Results In early 2018, Vesela Kovacheva, MD, PhD, an anesthesiologist for high-risk...

Innovators and innovators-to-be attended Brigham Ignite’s Ignitable Ideas event on April 12 to learn from industry members.

The Two Projects Focus on Robotic AI-Guided Intubation and Gamma Delta T Cell Therapy for Solid Tumors Boston, MA-March 3, 2023 Two...

Hear the latest trends on venture capital investing, how VCs look at an opportunity, and how to position ideas to raise financing. 

Brigham Ignite is pleased to announce the Ignitable Ideas Series, a virtual educational series for investigators to learn how innovation can

McKenna joined fellow panelists from GE Healthcare, Veranex, Becton Dickinson and Intuitive Surgical

The early-stage innovation acceleration program celebrated its first 11 award recipients at a special event at the Brigham this evening.

This article previously appeared in Brigham Clinical & Research News Getting cancer drugs to the correct locations is one of the biggest...

Four Brigham Ignite awards were announced today, bringing the total number of awards given to Brigham & Women’s Hospital innovators to 10.

Brigham Ignite, Brigham and Women’s early-stage innovation acceleration program, recently announced its first six award recipients.

For the research or clinical scientist, a discovery can be an exciting piece of a puzzle or a eureka moment in a life-long journey of study.

Then it hits you; Now What? This is no longer just an idea, it should be turned into something tangible to benefit science and healthcare...

You have completed your research project, possibly published the results, and maybe presented the work at a conference. Now what?

Patent basics like, How does the USPTO determine what is patentable?

The most common reason for the commercial failure of a start-up entity is not having a compelling clinical need. What exactly is an “unmet

Written by Ron Blackman What patient population are you targeting? While you have already identified the market need, you may find for...